1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow 16p11.2 Deletion Syndrome: new trials by email Literature Review of 16p11.2 Deletion Syndrome trials Research Report on 16p11.2 Deletion Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Efficacy of Arbaclofen in 16p11.2 Deletion Arbaclofen, Placebo oral tablet - 16P11.2 Deletion Syndrome | Phase 2 | Unknown | Clinical Research Associates, LLC | 60 | 2022-09-01 | 2024-05-30 |
Sugars (1) · arbaclofen placarbil (1)
Clinical Research Associates, LLC (1)
United States (1)
Paul Wang, MD (1)